ocr: INDUCTION THERAPY Ara-C, 100 mg/m IV q12h X - 7 days 6-Thioguanine, 100 mg/m? po q12h X - 7 days Daunorubicin, 60 mg/m IV days 5, . 6, 7 Patients Patient Population Achieving CR All participants (142 patients) 74 - - (52%) Minus patients unable to complete therapy 74 - (61%) (-20 patients) Above minus patients greater than 70 64 (82%) years ofage (-44 more patients) Above minus patients with antecedent 62 (85%) hematologic disorder (-5 more patients) Above minus patients with secondary AML 62( (91%) (-5 more patients)
